Contact Information:
Chris Lindsell, PhD, professor of Biostatistics & Bioinformatics at Duke, leads the visionary strategic planning, development, and execution of state-of-the-art research for the CTSI and the Duke Clinical Research Institute to achieve its scientific goals.
Lindsell has served as the Institute for Clinical and Translational Research Methods program director, co-director of the Center for Health Data Science, and professor of biostatistics and biomedical informatics at Vanderbilt University. He is a leader in the application of rigorous methods in the acute care environment, and to the intersection between emergency care and public health. He has led data coordinating centers for numerous multi-center clinical trials, including FDA-regulated trials, and epidemiological studies. His experience spans mechanistic studies, network trials, pragmatic trials, embedded trials, and more.
Lindsell holds patents for using clinical information, biomarkers, and transcriptomics for prognosis and prediction in sepsis and septic shock with a goal of precision therapy in critical illness. He has contributed to data standards for CONNECTS, NHLBI’s network of networks for COVID-19 research, and to the DAQCORD guidelines for data collection and curation in observational studies. He has published over 350 peer-reviewed papers, and most recently, he has been leading multiple major data center efforts during the Covid-19 pandemic including TREAT NOW, ACTIV6 and the IVY Network.